In one study, inducible MyD88/CD40 (iMC) CAR NK cells were extended to CAR NK cells and enhanced the tumor killing efficacy of CAR-NK by increasing cytotoxic function, cytokine secretion and proliferation. This evidence concerns the gene MYD88 and neoplasm.